Home>Topics>Authors>Alex Morozov

Alex Morozov

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Our Take on the Second Quarter

    Headlines

    Mon, 30 Jun 2014

    and consumer cyclical as looking particularly pricey right now. Morningstar director of European equity research Alex Morozov cautions that "aggregate analysis doesn't tell you the whole story" and that investors can still find some wonderful

  2. The Friday Five

    Video Reports

    Fri, 11 Apr 2014

    relatively low and these are pretty expensive systems and they're really kind of taking a very close look at this. But Alex Morozov , who covers Intuitive Surgical for us, really sees this as very much a short-term issue. Given that there are so

    Alex Morozov found at 6:33

    they're really kind of taking a very close look at this. But Alex Morozov , who covers Intuitive Surgical for us, really sees this as very much a short-term issue. Given that there are so many moving
  3. Americas: Regional Economic Review – 4Q 2013

    Headlines

    Tue, 1 Apr 2014

    pipets, storage containers, and cell cultures. The combination of these product lines is, in Morningstar analyst Alex Morozov 's opinion, a perfect mix, as it allows the firm to market itself as a one-stop shop for its research customers

  4. 5 Election Takeaways for Investors

    Video Reports

    Fri, 9 Nov 2012

    impact that the law will have, particularly on the managed health-care companies. Like you mentioned, I talked to Alex Morozov and Matt Coffina, who are our health-care analysts who have been following this very closely, and they really think

    Alex Morozov found at 3:42

    particularly on the managed health-care companies. Like you mentioned, I talked to Alex Morozov and Matt Coffina, who are our health-care analysts who have been following this very closely, and they really think there are still
  5. Finding Value in Health Care After the Election

    Video Reports

    Wed, 7 Nov 2012

    have on health-care stocks? I'm here today with Alex Morozov and Matt Coffina to take a look. Gentlemen, thanks for joining me today. Alex Morozov : Thanks for having us. Glaser: So it seems like

    Alex Morozov found at 0:09

    impact will the election have on health-care stocks? I'm here today with Alex Morozov and Matt Coffina to take a look. Gentlemen, thanks for joining me today. Alex Morozov : Thanks for having us. Glaser: So it seems like, when it comes to health-care reform, we've had a lot of barriers to
  6. Will Life Sciences Firms Fall Off the Fiscal Cliff?

    Video Reports

    Thu, 30 Aug 2012

    is looming large is life sciences. I'm here with Alex Morozov ; he is the director of health-care research at Morningstar ..... still any value there. Alex, thanks for joining me. Alex Morozov : Thanks for having me, Jeremy. Glaser : So, let

    Alex Morozov found at 0:13

    industry where this is looming large is life sciences. I'm here with Alex Morozov ; he is the director of health-care research at Morningstar. We're going to take a look at the industry and see if there is still any value there. Alex, thanks for joining me. Alex Morozov : Thanks for having me, Jeremy. Glaser : So, let's start with the sequestration; let's start with the cuts. What could these
  7. Congress Passes Comprehensive Health Reform

    Commentary

    Mon, 22 Mar 2010

    care goods , especially prescription drugs . Diagnostic companies and makers of generic drugs should also see higher utilization rates , providing strong support to these industries'growth . Alex Morozov , CFA contributed to this note .

  8. Merck KGaA to Buy Millipore

    Commentary

    Mon, 1 Mar 2010

    customer channel overlap. However, the price appears to be excessive even if additional synergies are extracted. Alex Morozov , CFA, and Damien Conover, CFA, contributed to this note.

  9. Millipore Evaluates Potential Takeover

    Commentary

    Thu, 25 Feb 2010

    has revealed that it is evaluating strategic alternatives. We will hold on to our fair value estimates for both companies until we hear more concrete evidence about the potential acquisition. Alex Morozov , CFA, contributed to this note.

« Prev12Next »
Content Partners